CH476707A - Verfahren zur Herstellung von 3-Enoläthern von 6-Formyl-3-oxo- 4-steroiden - Google Patents

Verfahren zur Herstellung von 3-Enoläthern von 6-Formyl-3-oxo- 4-steroiden

Info

Publication number
CH476707A
CH476707A CH1291061A CH1291061A CH476707A CH 476707 A CH476707 A CH 476707A CH 1291061 A CH1291061 A CH 1291061A CH 1291061 A CH1291061 A CH 1291061A CH 476707 A CH476707 A CH 476707A
Authority
CH
Switzerland
Prior art keywords
steroids
formyl
oxo
preparation
enol ethers
Prior art date
Application number
CH1291061A
Other languages
German (de)
English (en)
Inventor
Neville Kirk David
Petrow Vladimir
Original Assignee
British Drug Houses Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by British Drug Houses Ltd filed Critical British Drug Houses Ltd
Publication of CH476707A publication Critical patent/CH476707A/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J13/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J73/00—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J75/00—Processes for the preparation of steroids in general

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
CH1291061A 1960-11-07 1961-11-07 Verfahren zur Herstellung von 3-Enoläthern von 6-Formyl-3-oxo- 4-steroiden CH476707A (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB3823660A GB929983A (en) 1960-11-07 1960-11-07 6-formyl steroids

Publications (1)

Publication Number Publication Date
CH476707A true CH476707A (de) 1969-08-15

Family

ID=10402138

Family Applications (1)

Application Number Title Priority Date Filing Date
CH1291061A CH476707A (de) 1960-11-07 1961-11-07 Verfahren zur Herstellung von 3-Enoläthern von 6-Formyl-3-oxo- 4-steroiden

Country Status (6)

Country Link
BE (1) BE610054A (en:Method)
BR (1) BR6133972D0 (en:Method)
CH (1) CH476707A (en:Method)
FR (3) FR1563606A (en:Method)
GB (1) GB929983A (en:Method)
SE (1) SE301309B (en:Method)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3004508C2 (de) * 1980-02-05 1981-12-10 Schering Ag Berlin Und Bergkamen, 1000 Berlin Verfahren zur Herstellung von 6-Methylensteroiden
FR2724174B1 (fr) 1994-09-06 1997-01-17 Roussel Uclaf Procede de preparation d'un derive steroide 17beta-carboxy et nouveaux intermediaires

Also Published As

Publication number Publication date
GB929983A (en) 1963-06-26
BR6133972D0 (pt) 1973-05-15
FR1563607A (en:Method) 1969-04-18
FR1563606A (en:Method) 1969-04-18
BE610054A (fr) 1962-05-07
FR1563605A (en:Method) 1969-04-18
SE301309B (en:Method) 1968-06-04

Similar Documents

Publication Publication Date Title
CH430703A (de) Verfahren zur Herstellung von Phenyl-cycloalkanmethylaminen
AT288340B (de) Verfahren zur Herstellung von Aminonitroalkanen
CH430742A (de) Verfahren zur Herstellung von N-Alkoxy-B-phenyl-alkylaminen
CH429694A (de) Verfahren zur Herstellung von Phenoxyalkylguanidinen
CH395094A (de) Verfahren zur Herstellung von 6-Chlor-benzisothiazolon
AT248620B (de) Verfahren zur Herstellung von 10α-Methyl-Steroiden
CH441278A (de) Verfahren zur Herstellung von Benzolsulfonyl-cyclohexylharnstoffen
CH432508A (de) Verfahren zur Herstellung von 7a-Methylsteroiden
CH402859A (de) Verfahren zur Herstellung von a-Pyrrolidino-valerophenonen
CH412875A (de) Verfahren zur Herstellung von 6a-Methyl-16-methylen-steroiden
CH400167A (de) Verfahren zur Herstellung von Arylaminopyrazolen
CH451126A (de) Verfahren zur Herstellung von 3-Enoläthern von 2-Formyl-3-oxo-5a-steroiden
CH402848A (de) Verfahren zur Herstellung von 1a-Methyl-3-ketosteroiden
CH433280A (de) Verfahren zur Herstellung von 17a-Haloäthinylsteroiden
CH403756A (de) Verfahren zur Herstellung von 18-substituierten Steroiden
AT242867B (de) Verfahren zur Herstellung von Dihydroouabain
CH399449A (de) Verfahren zur Herstellung von 4-Hydroxy-3-keto- 4-steroiden
CH406231A (de) Verfahren zur Herstellung von 3-Hydroxymethyl-1-(5-nitrofurfuryliden-amino)-hydantoïn
CH383974A (de) Verfahren zur Herstellung von 2-Amino-oxazolen
CH385239A (de) Verfahren zur Herstellung von 5-Nitrofurfuralazinen
CH405329A (de) Verfahren zur Herstellung von Sulfanilamidothiadiazolen
CH401042A (de) Verfahren zur Herstellung von 3-Enoläthersteroiden
CH405307A (de) Verfahren zur Herstellung von 6a-Fluormethylsteroiden
CH393316A (de) Verfahren zur Herstellung von 9a-Halogen-steroiden
CH398581A (de) Verfahren zur Herstellung von 11B-hydroxylierten 16a-Methylsteroiden

Legal Events

Date Code Title Description
PL Patent ceased